-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRA PHARMACEUTICALS- NO CLINICALLY SIGNIFICANT DISSOCIATIVE OR PSYCHOTOMIMETIC EFFECTS OBSERVED IN PHASE 1 TRIAL OF KETAMIR-2 - SEC FILING

Reuters·03/03/2026 21:28:16

Please log in to view news